Escalon Medical Corp.
ESMC
$0.19
-$0.02-9.52%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 11.51% | -3.81% | -25.97% | 28.89% | 12.25% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 11.51% | -3.81% | -25.97% | 28.89% | 12.25% |
| Cost of Revenue | 23.61% | -0.87% | -27.70% | 18.72% | 2.41% |
| Gross Profit | -1.14% | -7.62% | -23.64% | 43.26% | 24.78% |
| SG&A Expenses | 14.11% | 0.74% | 3.76% | 3.72% | -1.87% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 17.81% | 2.49% | -11.75% | 12.13% | 0.85% |
| Operating Income | -61.43% | -651.11% | -368.84% | 276.25% | 462.98% |
| Income Before Tax | -60.28% | -645.03% | -382.59% | 267.49% | 422.41% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -60.28% | -645.03% | -382.59% | 267.49% | 422.41% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -60.28% | -645.03% | -382.59% | 267.49% | 422.41% |
| EBIT | -61.43% | -651.11% | -368.84% | 276.25% | 462.98% |
| EBITDA | -59.67% | -1,093.87% | -330.46% | 286.14% | 555.14% |
| EPS Basic | -64.46% | -459.02% | -268.90% | 177.54% | 238.33% |
| Normalized Basic EPS | -60.39% | -648.15% | -383.19% | 267.15% | 423.44% |
| EPS Diluted | -64.46% | -241.00% | -275.61% | 177.54% | 238.33% |
| Normalized Diluted EPS | -61.47% | -648.15% | -383.19% | 187.59% | 270.31% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 2.43% | 0.00% | 0.00% | 91.04% | 89.90% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |